Pancreatic cancer vaccine shows promise

New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,
New mRNA Vaccine Against World's Biggest Infectious Killer Shows Promise
A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently approved vaccine for TB – which recently surpassed COVID-19 to once again become the deadliest infectious disease on Earth – the findings are a great step forward in the quest to combat humanity’s ancient foe.
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
Vaccine Shows Promise for Pancreatic Cancer, Study Finds
The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and attack the tumor. During surgery, doctors removed each patient’s tumor and sent it to the German biotechnology company BioNTech.
Trial shows promise of mRNA vaccines in treating pancreatic cancer
A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. The phase 1 trial results, published Feb. 19 in Nature,
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
justthenews1d
Yale research validates spike protein persistence from COVID vaccines as injury visibility rises
Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...
Bill to ban mRNA vaccines passes out of House committee
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
The Daily Pennsylvanian3d
Here’s how Penn researchers are using mRNA technology to treat cancer, celiac disease
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Franklin County wants health district to stop offering COVID vaccines
An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...
Montana seeks to ban mRNA shots as vaccine hesitancy soars
Health Secretary Robert F. Kennedy Jr. is a noted vaccine skeptic, and President Donald Trump has expressed concerns about ...
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...